Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC729562 Inhibitors

Compounds such as Staurosporine and Chelerythrine exert their effects by targeting protein kinases, which are pivotal in regulating the phosphorylation and thus the activity states of numerous proteins. By inhibiting these kinases, the activation status of proteins like LOC729562 can be altered, leading to changes in their function. PI3K and mTOR, critical regulators of cell growth and survival, are specifically targeted by LY294002 and Rapamycin, respectively. The inhibition of these pathways can lead to changes in the cell's physiological state, which may suppress the activity of associated proteins, including LOC729562. U0126 and PD98059 similarly target the MAPK/ERK signaling cascade, a central pathway in controlling cell division, which can indirectly affect the function of a multitude of proteins.

Compounds such as Cycloheximide and Brefeldin A disrupt fundamental cellular processes like protein synthesis and transport, potentially leading to reduced levels or incorrect localization of various proteins. Wiskostatin's influence on the actin polymerization pathway and SP600125's modulation of stress-activated protein kinase pathways can have significant repercussions on the cellular architecture and stress responses, influencing the activity of a broad spectrum of proteins.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent protein kinase inhibitor that can disrupt various signaling pathways by inhibiting protein kinases that may regulate LOC729562.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A phosphatidylinositol 3-kinase (PI3K) inhibitor that can alter signaling pathways potentially influencing LOC729562 activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

A MEK inhibitor which can interrupt the MAPK/ERK pathway that might modulate LOC729562 function.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor that can affect signaling pathways relevant to protein synthesis and degradation, possibly affecting LOC729562.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Inhibits protein synthesis by interfering with the translocation step in protein synthesis, potentially reducing LOC729562 levels.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Disrupts protein transport by blocking the function of the Golgi apparatus, potentially affecting LOC729562 localization and function.

Wiskostatin

253449-04-6sc-204399
sc-204399A
sc-204399B
sc-204399C
1 mg
5 mg
25 mg
50 mg
$48.00
$122.00
$432.00
$812.00
4
(1)

Inhibits the activity of N-WASP, which is a part of the actin polymerization pathway, potentially impacting LOC729562 if it interacts with the cytoskeleton.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor, which can modulate stress-activated protein kinase pathways that might influence LOC729562 activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An inhibitor of MEK, which can disrupt the MAPK/ERK pathway potentially affecting LOC729562 function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor, potentially altering the activity of proteins in response to stress signals that might regulate LOC729562.